Chemohyperthermia with Mitomycin-C Compared with Bacillus Calmette-Guérin: A "Hot" Topic

Affiliations

¹ Department of Urology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands. Electronic address: j.oddens@jbz.nl.
² Senior Statistical Scientist Emeritus, European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium.

Editorial

Jorg R Oddens et al. Eur Urol. 2016 Jun.

. 2016 Jun;69(6):1053-4.

doi: 10.1016/j.eururo.2016.01.038. Epub 2016 Feb 9.

¹ Department of Urology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands. Electronic address: j.oddens@jbz.nl.
² Senior Statistical Scientist Emeritus, European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium.

No abstract available

Comment on

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
Arends TJ, Nativ O, Maffezzini M, de Cobelli O, Canepa G, Verweij F, Moskovitz B, van der Heijden AG, Witjes JA. Arends TJ, et al. Eur Urol. 2016 Jun;69(6):1046-52. doi: 10.1016/j.eururo.2016.01.006. Epub 2016 Jan 20. Eur Urol. 2016. PMID: 26803476 Clinical Trial.